Tiziana Life Sciences (TILS)

 

TILS Share PerformanceMore

52 week high210.00 08/06/17
52 week low55.00 23/05/18
52 week change -116.00 (-61.05%)
4 week volume377,333 28/04/18
price74.00
price date1527169260
close72.00

Latest NewsMore

Second Price Monitoring Extn

RNS Number: 0882P Tiziana Life Sciences PLC 23 May 2018 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined...

Price Monitoring Extension

RNS Number: 0876P Tiziana Life Sciences PLC 23 May 2018 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the executi...

Tiziana Life Sciences gets positive drug tolerability evaluation

Tiziana Life Sciences, which is developing drugs targeting cancer and inflammatory diseases, said it had received a positive...

Milciclib Phase 2a Trial - Tolerability Update

RNS Number: 1999O Tiziana Life Sciences PLC 16 May 2018 Tiziana Life Sciences plc ("Tiziana" or the "Company") Tiziana Life Sciences Announces Interim Analysis Data from an Ongoing Phase 2a Trial of Milciclib Safety and Tolerability in Sorafenib-refractory or -intolerable, Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Patients Treatment with ...

Grant of Options - Director Dealing

RNS Number: 7744M Tiziana Life Sciences PLC 01 May 2018 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Grant of options - Director's dealing London, 1 May 2018 - Tiziana Life Sciences plc (AIM: TILS), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that the remuneration com...

Issue of Equity

RNS Number: 3188M Tiziana Life Sciences PLC 27 April 2018 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Issue of equity 27 April 2018 Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has allotted 23,014 ordinary shares in the Company a...

Tiziana raises £825,000

Tiziana Life Sciences, a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune disea...

Subscription

RNS Number: 3791L Tiziana Life Sciences PLC 19 April 2018 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Subscription raising 825,000 London, April 19, 2018 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has raised 825,000 i...

Fundamental DataMore

EPS-7.7
Dividend yield0 %

Latest discussion posts More

  • Re: shock and awe!!!

    Back to reality during the day but closes @ 147.5 up 50.5%. If only!
    9-Mar-2018
    osammyboy
  • shock and awe!!!

    Just opened my Barclays portfolio, Tils up 54.4% to 147.5. I wish. Back down to earth with a thump
    8-Mar-2018
    osammyboy
  • Re: trades

    Don't panic, Don't panic Totally misread that sale 10000 shares total #11200
    6-Feb-2018
    osammyboy

Users' HoldingsMore

Users who hold Tiziana Life Sciences also hold..

Codes & Symbols

ISINGB00BKWNZY55
SymbolsTILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS